Finance

Lists
BAYZF:OTCMKTS
Bayer AG
56,89 US$
0,00%
(0,00) 1D
6 აგვ, 09:34:49 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BAYZF...
Mkt. cap
55,46 მლრდ.
Avg. vol.
7,72 ათ.
Volume
407,00
52-wk high
61,38 US$
52-wk low
29,80 US$
Beta
0,52
Shares outstanding
982,42 მლნ.
No. of employees
88 ათ.
Mkt. cap
55,46 მლრდ.
Avg. vol.
7,72 ათ.
Volume
407,00
52-wk high
61,38 US$
52-wk low
29,80 US$
Beta
0,52
Shares outstanding
982,42 მლნ.
No. of employees
88 ათ.
News stories
From web sources and news partners
Profile
Bayer AG is a German multinational pharmaceutical and biotechnology company and is one of the largest pharmaceutical companies and biomedical companies in the world. Headquartered in Leverkusen, Bayer's areas of business include pharmaceuticals, consumer healthcare products, agricultural chemicals, seeds and biotechnology products. The company is a component of the EURO STOXX 50 stock market index. Bayer was founded in 1863 in Barmen as a partnership between dye salesman Friedrich Bayer and dyer Johann Friedrich Weskott. The company was established as a dyestuffs producer, but the versatility of aniline chemistry led Bayer to expand its business into other areas. In 1899, Bayer launched the compound acetylsalicylic acid under the trademarked name Aspirin. Aspirin is on the World Health Organization's List of Essential Medicines. In 2021, it was the 34th most commonly prescribed medication in the United States, with more than 17 million prescriptions. In 1904, Bayer received a trademark for the "Bayer Cross" logo, which was, from 1910, subsequently stamped onto each aspirin tablet, creating an enduring brand image. Wikipedia
About Bayer AG
CEOბილ ანდერსონი
Employees87,8 ათ.
Founded1 აგვ. 1863
Headquarters-
SectorPharmaceutical industry
Websitebayer.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
9,66 მლრდ.
11,44 მლრდ.
13,40 მლრდ.
10,87 მლრდ.
Cost of goods sold
4,31 მლრდ.
4,23 მლრდ.
5,23 მლრდ.
4,52 მლრდ.
Cost of revenue
4,31 მლრდ.
4,23 მლრდ.
5,23 მლრდ.
4,52 მლრდ.
Research and development expenses
1,50 მლრდ.
1,29 მლრდ.
1,42 მლრდ.
1,51 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,40 მლრდ.
5,37 მლრდ.
3,70 მლრდ.
3,94 მლრდ.
Operating expense
5,90 მლრდ.
3,89 მლრდ.
4,64 მლრდ.
5,35 მლრდ.
Total operating expenses
10,20 მლრდ.
8,12 მლრდ.
9,88 მლრდ.
9,87 მლრდ.
Operating income
-543,00 მლნ.
3,32 მლრდ.
3,53 მლრდ.
999,00 მლნ.
Other non operating income
-7,00 მლნ.
1,51 მლრდ.
-55,00 მლნ.
-329,00 მლნ.
EBT including unusual items
-1,16 მლრდ.
-3,37 მლრდ.
2,99 მლრდ.
321,00 მლნ.
EBT excluding unusual items
-1,16 მლრდ.
4,63 მლრდ.
2,99 მლრდ.
502,00 მლნ.
Income tax expense
-202,00 მლნ.
378,00 მლნ.
222,00 მლნ.
92,00 მლნ.
Effective tax rate
17,40%
-11,21%
7,43%
28,66%
Other operating expenses
993,00 მლნ.
-2,76 მლრდ.
-470,00 მლნ.
-97,00 მლნ.
Net income
-963,00 მლნ.
-3,76 მლრდ.
2,76 მლრდ.
219,00 მლნ.
Net profit margin
-9,97%
-32,85%
20,61%
2,01%
Earnings per share
0,57
-
-
-
Interest and investment income
-
471,00 მლნ.
-
-
Interest expense
-539,00 მლნ.
-527,00 მლნ.
-474,00 მლნ.
-81,00 მლნ.
Net interest expenses
-539,00 მლნ.
-56,00 მლნ.
-474,00 მლნ.
-81,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
412,00 მლნ.
4,72 მლრდ.
4,76 მლრდ.
2,16 მლრდ.
Gain or loss from assets sale
-33,00 მლნ.
-191,00 მლნ.
-161,00 მლნ.
-14,00 მლნ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები